# China NMPA Drug Inspection - Jichuan Pharmaceutical Group Co., Ltd. - Pudilan Anti-inflammatory Oral Liquid

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/jichuan-pharmaceutical-group-co-ltd/680165cd-418d-42bc-8d7e-d16c9f2613c8/
Source feed: China

> China NMPA drug inspection for Jichuan Pharmaceutical Group Co., Ltd. published March 20, 2020. Drug: Pudilan Anti-inflammatory Oral Liquid. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Gansu Provincial Drug Administration Regarding Sampling Inspection Information of Drugs Used for COVID-19 Prevention and Control
- Company Name: Jichuan Pharmaceutical Group Co., Ltd.
- Publication Date: 2020-03-20
- Drug Name: Pudilan Anti-inflammatory Oral Liquid
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/jichuan-pharmaceutical-group-co-ltd/d4e308ef-ff84-49c5-a518-077c305cad54/